Actavis Laboratories FL, Inc. – FDA 483, May 25, 2021
Actavis Laboratories FL, Inc. in Davie, FL, received a Form 483 with five observations during an FDA inspection. The firm demonstrated significant deficiencies in its quality control investigations, including inadequate root cause analysis and product impact assessments for out-of-specification results. Additional issues included a lack of microbial testing for certain non-sterile drug products, failure to maintain equipment calibration, incomplete master batch records, and deficient procedures for handling customer complaints.
ID · 2670fdae-0b75-4049-a5ee-0826fd79c779
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.